Health & Environmental Research Online (HERO)


Print Feedback Export to File
3857365 
Journal Article 
Estrogenic effects of fluorotelomer alcohols for human estrogen receptor isoforms alpha and beta in vitro 
Ishibashi, H; Ishida, H; Matsuoka, M; Tominaga, N; Arizono, K 
2007 
Yes 
Biological and Pharmaceutical Bulletin
ISSN: 0918-6158
EISSN: 1347-5215 
PHARMACEUTICAL SOC JAPAN 
TOKYO 
30 
1358-1359 
English 
The present study demonstrates the estrogenic effects of fluorotelomer alcohols (FTOHs). In a yeast two-hybrid assay, treatment with 1H,1H,2H,2H-perfluorooctan-1-ol (6:2 FTOH), 1H,1H,2H,2H-perfluoro-decan-1-ol (8:2 FTOH) and 2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-nonadecafluoro-1-decanol (NFDH) showed a dose-dependent interaction between the human estrogen receptor (hER) isoforms hERalpha or hERbeta ligand-binding domain and coactivator TIF2, whereas there were no estrogenic effects of perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) for these hERs. The estrogenic effects of FTOHs on hERalpha were higher than those on hERbeta, indicating a differential responsiveness of hERs to FTOHs. The relative ranks of tested chemicals on the estrogenic effects for hERalpha and hERbeta descended in the order of estradiol-17beta>6:2 FTOH>NFDH>8:2 FTOH. These results suggest that certain FTOHs including 6:2 FTOH, 8:2 FTOH and NFDH interact with hER isoforms alpha and beta in vitro. Further studies are necessary to investigate contamination levels, potential biological effects and the risks of these compounds on human health. 
human estrogen receptor alpha; human estrogen receptor beta; fluorotelomer alcohols; estrogenic effect 
• Additional PFAS (formerly XAgency)
• Expanded PFAS SEM (formerly PFAS 430)
     Litsearch: September 2019
          PubMed
          Web of Science
     Screened Studies
          Supplemental
     9:1 Fluorotelomer alcohol
     Perfluorooctane
     3:2 Fluorotelomer alcohol
• FtOH 6:2
     Screening Results
          In vitro/ex vivo/in silico
               Endocrine disruption
• FtOH 8:2
     Literature Search
          Pubmed
          WOS
     Screening Results
          In vitro/ex vivo/in silico
               Endocrine disruption
• ^Per- and Polyfluoroalkyl Substances (PFAS)
     FtOH 8:2 (678-39-7)
          Literature Search
               Pubmed
               WOS
     FtOH 6:2 (647-42-7)
          Literature Search
               Pubmed
               WOS
• PFAS 150
     Literature Search Update December 2020
          PubMed
          WOS
     Literature Search August 2019
          PubMed
          Web of Science
     Not prioritized for screening
     6:2 Fluorotelomer alcohol
     7:3 Fluorotelomer alcohol
     8:2 Fluorotelomer alcohol
     Ammonium perfluorooctanoate
     Perfluorooctane
     Perfluorooctanesulfonic acid
     Perfluorooctanoic acid